AstraZeneca
-
Health
AstraZeneca launches global R&D Postdoctoral Challenge to accelerate scientific discovery and diversity
AstraZeneca has launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the…
Read More » -
Health
New AstraZeneca COVID-19 vaccine data further support its use as third dose booster
Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial (D7220C00001) showed that AstraZeneca COVID-19 vaccine (ChAdOx1-S…
Read More » -
Health
Omicron: University of Oxford study supports use of COVID-19 Vaccine AstraZeneca
AstraZeneca’s COVID-19 Vaccine (ChAdOx1-S [Recombinant]) significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529) following a third dose…
Read More » -
Health
COVID-19: AstraZeneca’s Evusheld authorised for emergency use in the US
As part of efforts to enhance the fight against COVID-19 pandemic, AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody…
Read More »